Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Spiros Tzivelekis"'
Autor:
Brett Hauber, John Caloyeras, Joshua Posner, Deborah Brommage, Spiros Tzivelekis, Allan Pollock
Publikováno v:
BMC Nephrology, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Background Patient engagement in end-stage renal disease (ESRD) is expected to result in a more patient-centered approach to care that aligns with patients’ values, preferences, and goals for treatment. Nevertheless, no previous studies of
Externí odkaz:
https://doaj.org/article/c10ddf9ea9434f9abb253a8c940521a6
Autor:
Spiros Tzivelekis, Jordan Orange, Christine Poulos, Lisa M Meckley, Holly Peay, Jessie Sutphin, Vivian P Hernandez-Trujillo, Richard L Wasserman
Publikováno v:
Immunotherapy. 15:647-656
Aim: To describe development of a shared decision making (SDM) aid in treating primary immunodeficiency diseases (PID) with immunoglobulin replacement therapy (IGRT). Materials & methods: Expert engagement and qualitative formative research informed
Autor:
Ping Du, Aurore Bergamasco, Yola Moride, Françoise Truong Berthoz, Gülden Özen, Spiros Tzivelekis
Publikováno v:
Journal of Blood Medicine. 14:189-208
Autor:
Nisha, Jain, Johannes, Oldenburg, Margareth C, Ozelo, Shawn X, Sun, Leilei, Tang, Spiros, Tzivelekis
Publikováno v:
Expert Review of Hematology. 15:1-18
Hemophilia, von Willebrand disease (VWD), and thrombotic thrombocytopenic purpura (TTP) are rare diseases affecting normal hemostasis. Although they differ in their pathogenesis and clinical manifestation, if left undiagnosed and untreated, all these
Autor:
Katrina Wilcox Hagberg, Susan Jick, Ping Du, Françoise Truong Berthoz, Gülden Özen, Spiros Tzivelekis
Publikováno v:
Journal of women's health (2002). 31(9)
Autor:
Clara Monleón Bonet, Nathalie Waser, Karen Cheng, Silvia Sánchez-Ramón, J David M Edgar, Spiros Tzivelekis
Publikováno v:
Expert Review of Clinical Immunology. 16:911-921
Introduction Secondary immunodeficiency diseases (SID) caused by hematological malignancies (HMs), stem cell transplant (SCT), and associated therapies are mainly characterized by the presence of hypogammaglobulinemia or antibody production deficits.
Publikováno v:
Annals of Allergy, Asthma & Immunology. 127:568-574.e1
Background The safety and efficacy of subcutaneous immune globulin 20% (human) solution (Cuvitru; Ig20Gly) for primary immunodeficiency disease (PID) have been demonstrated in 2 pivotal trials. Objective To describe patient characteristics and infusi
Publikováno v:
Supportive Care in Cancer. 26:539-548
The purpose of this study is to assess temporal trends in the use of granulocyte colony-stimulating factor (G-CSF) prophylaxis and risk of febrile neutropenia (FN) among older women receiving adjuvant chemotherapy for early-stage breast cancer. Women
Autor:
Spiros Tzivelekis, Brett Hauber, John P. Caloyeras, Allan Pollock, Joshua Posner, Deborah Brommage
Publikováno v:
BMC Nephrology, Vol 18, Iss 1, Pp 1-9 (2017)
BMC Nephrology
BMC Nephrology
Background Patient engagement in end-stage renal disease (ESRD) is expected to result in a more patient-centered approach to care that aligns with patients’ values, preferences, and goals for treatment. Nevertheless, no previous studies of which we
Autor:
Guillermo Villa, Milton C. Weinstein, Kelly Fust, Qing Gu, Xiaoyan Li, Spiros Tzivelekis, Gary H. Lyman, Michael Maschio, Anju Parthan
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 17:39-52
Introduction: We reviewed the evolution of the methods used in cost-effectiveness analyses of granulocyte colony-stimulating factors (G-CSFs) in the primary and secondary prevention of febrile neutropenia (FN) in patients receiving myelosuppressive c